 STAMFORD, Conn., Dec. 27, 2022 GLOBE NEWSWIRE SpringWorks Therapeutics, Inc. Nasdaq: SWTX, a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, announced today that the Company has completed the submission of a New Drug Application NDA to the United States Food and Drug Administration FDA for ... The post SpringWorks Therapeutics Completes Submission of New Drug Application to the FDA for Nirogacesta... 